EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

m 6 A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway

Xiao-Fei Gao iD, Ai-Qun Chen iD, Hao-Yue Tang iD, Xiang-Quan Kong iD, Huan Zhang, Zhi-Mei Wang iD, Wei Lu iD, Li-Guo Wang, Feng Wang iD, Wen-Ying Zhou iD, Yue Gu iD, Guang-Feng Zuo iD und 3 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2024-12 · 44 (12) · 2543-2559

DOI: 10.1161/atvbaha.124.321399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024-12. Verfasst von Xiao-Fei Gao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, China. Hauptthemen laut MEDLINE: Neointima, Muscle, Smooth, Vascular, Hyperplasia, Phenotype. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In-stent restenosis is characterized by a significant reduction in lumen diameter within the stented segment, primarily attributed to excessive proliferation of vascular smooth muscle cells (VSMCs) and neointimal hyperplasia. PFN1 (profilin-1), an actin-sequestering protein extensively studied in amyotrophic lateral sclerosis, remains less explored in neointimal hyperplasia. METHODS: Utilizing single-cell RNA sequencing alongside data from in-stent restenosis patients and various experimental in-stent restenosis models (swine, rats, and mice), we investigated the role of PFN1 in promoting VSMC phenotype switching and neointimal hyperplasia. RESULTS: Single-cell RNA sequencing of stenotic rat carotid arteries revealed a critical role for PFN1 in neointimal hyperplasia, a finding corroborated in stented swine coronary arteries, in-stent restenosis patients, PFN1 SMC-IKO (SMC-specific PFN1 knockout) mice, and PFN1 overexpressed mice. PFN1 deletion was shown to suppress VSMC phenotype switching and neointimal hyperplasia in PFN1 SMC-IKO mice subjected to a wire-injured model. To elucidate the observed discordance in PFN1 mRNA and protein levels, we identified that METTL3 (N 6 -methyladenosine methyltransferase) and YTHDF3 (YTH N6-methyladenosine RNA binding protein F3; N 6 -methyladenosine–specific reader) enhance PFN1 translation efficiency in an N 6 -methyladenosine–dependent manner, confirmed through experiments involving METTL3 knockout and YTHDF3 knockout mice. Furthermore, PFN1 was mechanistically found to interact with the phosphorylation of ANXA2 (annexin A2) by recruiting Src (SRC proto-oncogene, nonreceptor tyrosine kinase), promoting the phosphorylation of STAT3 (signal transducer and activator of transcription 3), a typical transcription factor known to induce VSMC phenotype switching. CONCLUSIONS: This study unveils the significance of PFN1 N 6 -methyladenosine modification in VSMCs, demonstrating its role in promoting phenotype switching and neointimal hyperplasia through the activation of the p-ANXA2 (phospho-ANXA2)/STAT3 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeointimaMuscle, Smooth, VascularHyperplasiaPhenotypeSTAT3 Transcription FactorMyocytes, Smooth MuscleSignal TransductionDisease Models, AnimalProto-Oncogene MasProfilinsMice, KnockoutAdenosineAnimalsMaleHumansMiceMice, Inbred C57BLRatsCells, CulturedRats, Sprague-DawleyPhosphorylationCoronary RestenosisCarotid StenosisCell Proliferation

Stichwörter der Autor:innen

coronary artery diseasehyperplasiamuscle, smooth, vascularpercutaneous coronary interventionprofilins

Substanzen

STAT3 Transcription FactorProto-Oncogene MasProfilinsAdenosineN-methyladenosineMAS1 protein, humanStat3 protein, mouseStat3 protein, rat

Autor:innen und Institutionen

  • Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, China.

ORCID-Profile: Xiao-Fei Gao, Ai-Qun Chen, Hao-Yue Tang, Xiang-Quan Kong, Zhi-Mei Wang, Wei Lu, Feng Wang, Wen-Ying Zhou, Yue Gu, Guang-Feng Zuo, Jun-Jie Zhang, Shao-Liang Chen

Zitieren

APA

Gao, X. F., Chen, A. Q., Tang, H. Y., Kong, X. Q., Zhang, H., Wang, Z. M., Lu, W., Wang, L. G., Wang, F., Zhou, W. Y., Gu, Y., Zuo, G. F., Ge, Z., Zhang, J. J., & Chen, S. L. (2024). m 6 A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway. Arteriosclerosis, Thrombosis, and Vascular Biology, 44(12), 2543-2559. https://doi.org/10.1161/atvbaha.124.321399

Vancouver

Gao XF, Chen AQ, Tang HY, Kong XQ, Zhang H, Wang ZM, et al. m 6 A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024;44(12):2543-2559. doi:10.1161/atvbaha.124.321399

BibTeX
@article{Gao2024,
  author = {Gao, Xiao-Fei and Chen, Ai-Qun and Tang, Hao-Yue and Kong, Xiang-Quan and Zhang, Huan and Wang, Zhi-Mei and Lu, Wei and Wang, Li-Guo and Wang, Feng and Zhou, Wen-Ying and Gu, Yue and Zuo, Guang-Feng and Ge, Zhen and Zhang, Jun-Jie and Chen, Shao-Liang},
  title = {m 6 A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2024},
  volume = {44},
  number = {12},
  pages = {2543--2559},
  doi = {10.1161/atvbaha.124.321399}
}
Kostenlos starten →